BIOTECHNOLOGY’S IMPACT ON DISEASES OF THE ELDERLY

September 1, 2000

“Biotechnology’s Impact on Diseases of the Elderly: A White Paper” describes the costs of these eight age-related illnesses in human and economic terms. It also examines some of the biotech medicines on the market and in development to treat the diseases and details their impact on patients’ quality of life and health-care expenditures.

Spotlight

Vipergen ApS

Vipergen is commercializing two proprietary technologies: 1) YoctoReactor® technology for the creation of DNA-encoded small-molecule libraries (drug-like, small molecule libraries with millions of members in a single tube format), and 2) Binder Trap Enrichment® for interrogation of DNA-encoded small-molecule libraries.

OTHER WHITEPAPERS
news image

Producing therapeutic peptides using biotechnology

whitePaper | October 20, 2022

We began the project by working to the design of a recombinant bacterial strain selection of a strain capable of producing high concentrations of peptides.

Read More
news image

Characterization and identification of glucuronide metabolites

whitePaper | April 21, 2023

This technical note demonstrates the comprehensive characterization and confident identification of glucuronide metabolites from hepatocyte incubations of midazolam. An orthogonal fragmentation mechanism was applied to generate diagnostic fragmentions for confident identification of glucuronide metabolites

Read More
news image

Best Practices for RIM Business Process Automation

whitePaper | December 15, 2022

Regulatory teams at life science companies are finding that effective regulatory information management (RIM) has become critical to their operations.

Read More
news image

GMP Grade PMSF and Protease Inhibitors

whitePaper | February 23, 2023

Phenylmethylsulfonyl fluoride, better known as PMSF, is a small molecule serine protease inhibitor used to prevent unwanted proteolysis.

Read More
news image

2022 Global Life Sciences Outlook

whitePaper | January 7, 2022

While valuations for the life sciences sector in this past year have been mixed, the underlying performance and outlook for the sector is healthy

Read More
news image

The colors of life: an interdisciplinary artist-in-residence project to research fungal pigments as a gateway

whitePaper | January 10, 2022

Biological pigmentation is one of the most intriguing traits of many fungi. It holds signifcance to scientists, as a sign of biochemical metabolism and organism-environment interaction, and to artists, as the source of natural colors that capture the beauty of the microbial world.

Read More

Spotlight

Vipergen ApS

Vipergen is commercializing two proprietary technologies: 1) YoctoReactor® technology for the creation of DNA-encoded small-molecule libraries (drug-like, small molecule libraries with millions of members in a single tube format), and 2) Binder Trap Enrichment® for interrogation of DNA-encoded small-molecule libraries.

Events